Extracorporeal life support system and methods of use thereof

Patent metadata

Field	Value
Publication number	US-10864131-B2
Application number	US-201816107115-A
Country	US
Kind code	B2
Filing date	Aug 21, 2018
Priority date	Mar 15, 2013
Publication date	Dec 15, 2020
Grant date	Dec 15, 2020

Abstract

Extracorporeal membrane oxygenation systems and methods of use are disclosed. Several publications and patent documents are cited throughout the specification in order to describe the state of the art to which this invention pertains. Full citations of these references can be found throughout the specification. Each of these citations is incorporated herein by reference as though set forth in full.

First claim

What is claimed:

1. A method for supporting a human premature fetus in an extrauterine life support system, the method comprising the steps of:
cannulating the premature fetus to a pumpless oxygenation circuit such that the pumpless oxygenation circuit defines a premature fetus blood path that includes a first portion that provides blood outflow from the premature fetus to an inflow port of an oxygenator, a second portion that passes through the oxygenator from the inflow port to an outflow port of the oxygenator, and a third portion that provides return blood flow from the outflow port to the premature fetus;
positioning the premature fetus inside an incubation chamber;
sealing the incubation chamber with the cannulated premature fetus inside the incubation chamber to form a water-tight internal environment for the premature fetus;
transferring a synthetic amniotic liquid from a supply tank defining a first volume into the incubation chamber defining an internal incubation chamber volume, the first volume being greater than the internal incubation chamber volume;
submerging the premature fetus in the synthetic amniotic liquid inside the incubation chamber;
priming the oxygenator with either fetal or maternal blood;
circulating fetal blood from the premature fetus to the oxygenator and back from the oxygenator to the premature fetus through the pumpless oxygenation circuit wherein the circulating fetal blood is pumped by the premature fetus; and
periodically draining at least a portion of the synthetic amniotic liquid from the incubation chamber and in response to the draining step transferring fresh synthetic amniotic liquid from the supply tank into the incubation chamber.

2. The method of claim 1 further comprising flowing an oxygen-containing sweep gas into the oxygenator and flowing an oxygenator exhaust gas from the oxygenator.

3. The method of claim 2 wherein the oxygen-containing sweep gas has an oxygen content and further comprising monitoring the oxygen content of the oxygen-containing sweep gas.

4. The method of claim 3 wherein the oxygenator exhaust gas has an oxygen content and further comprising monitoring the oxygen content of the oxygenator exhaust gas.

5. The method of claim 4 wherein the oxygen-containing sweep gas has a flow rate into the oxygenator and further comprising monitoring the flow rate of the oxygen-containing sweep gas into the oxygenator.

6. The method of claim 5 further comprising calculating an oxygen consumption across the oxygenator.

7. The method of claim 6 wherein the oxygenator exhaust gas has a carbon dioxide content and further comprising monitoring the carbon dioxide content of the oxygenator exhaust gas.

8. The method of claim 6 wherein the oxygen-containing sweep gas is a blended gas mixture of gaseous oxygen supplied from an oxygen gas source and gaseous air supplied from an air gas source.

9. The method of claim 6 further comprising the step of removing fetal waste products from the sealed incubation chamber via a suction device through a water-tight seal on the incubation chamber wherein the step of removing fetal waste products is accomplished without opening the sealed incubation chamber.

10. The method of claim 6 wherein the incubation chamber is a medical grade plastic bag or sac.

11. The method of claim 6 wherein the oxygenator is a polymethyl pentene hollow fiber membrane oxygenator.

12. The method of claim 6 wherein the first portion of the pumpless oxygenation circuit includes a cannula and tubing wherein the tubing is about 12 inches or less and extends between the cannula and the oxygenator.

13. The method of claim 1 further comprising the step of removing fetal waste products from the sealed incubation chamber via a suction device through a water-tight seal on the incubation chamber wherein the step of removing fetal waste products is accomplished without opening the sealed incubation chamber.

14. The method of claim 1 wherein the incubation chamber is a medical grade plastic bag or sac.

15. The method of claim 1 wherein the oxygenator is a polymethyl pentene hollow fiber membrane oxygenator.

16. The method of claim 1 wherein the first portion of the pumpless oxygenation circuit includes a cannula and tubing wherein the tubing is about 12 inches or less and extends between the cannula and the oxygenator.

Assignees

• Childrens Hospital Philadelphia

Inventors

• Flake Alan
• Partridge Emily
• Davey Marcus

Classifications

• A61M1/1698 Primary

  Blood oxygenators with or without heat-exchangers (intracorporal A61M1/1678; manufacturing of membranes therefor B01D67/00; semi-permeable membranes for separation processes characterised by their properties B01D69/00; semi-permeable membranes characterised by their material B01D71/00) · CPC title

• A61M1/3623

  Means for actively controlling temperature of blood · CPC title

• A61M1/168 Primary

  Sterilisation or cleaning before or after use · CPC title

• A61M2205/3331

  Pressure; Flow · CPC title

• A61M2205/3368

  Temperature · CPC title